Study of Personalized Cancer Therapy to Determine Response and Toxicity

Part of paid clinical trials in La Jolla, California.

Sponsor
Shu Mei Kato
Study ID
NCT02478931
Status
Recruiting

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
7 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information about the tests and treatments a person received, or will receive, for their cancer will be collected from medical records to help the researchers determine whether or not patients respond better when their physicians choose to treat them according to the genetic makeup of their tumor. Optional research tests may be performed on tissue, body cavity fluid, blood or urine provided, discarded biological samples taken during routine care that would normally be disposed of and not saved, or on blood samples collected for this study. These research tests will be used to create a "profile" of the collected specimens which will describe unique characteristics about the genes involved in a person's cancer. The tests will also help researchers look for biomarkers that may help predict how people respond to treatment.

Key Dates

Start date
Sep 5, 2013
Status verified
Mar 2026
Primary completion
Sep 5, 2026
Completion
Sep 5, 2027

Study Design

Enrollment
10,000 participants (estimated)

Primary Outcome Measure

Comparison of Tumor Biomarker Profiling to Treatment Outcome [ Time Frame: 4 years ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
UCSD Moores Cancer CenterLa JollaCalifornia92093
Suzanna Lee
858-534-1306
Eisenhower Medical Center, Lucy Curci Cancer CenterRancho MirageCalifornia92270
Stephanie W Farrell, MBA
760-837-8034
Henry Tsai, MD (PRINCIPAL_INVESTIGATOR)
Rady Children's Hospital, San DiegoSan DiegoCalifornia92123
Neera Gundrania, MPH
858-966-8823
Dennis Kuo, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in La Jolla, CA

Related Studies